DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,420 | +3.3% | 46,050 | -0.0% | 2.20% | +8.1% |
| Q2 2023 | $11,054 | -8.9% | 46,060 | -4.4% | 2.03% | -15.6% |
| Q1 2023 | $12,138 | -7.2% | 48,166 | -2.4% | 2.41% | -14.9% |
| Q4 2022 | $13,084 | -99.9% | 49,375 | -0.3% | 2.83% | -4.5% |
| Q3 2022 | $12,777,000 | +1.4% | 49,524 | -0.2% | 2.96% | +4.4% |
| Q2 2022 | $12,599,000 | -13.3% | 49,604 | +0.0% | 2.84% | +3.0% |
| Q1 2022 | $14,533,000 | -10.4% | 49,601 | +0.7% | 2.76% | -2.4% |
| Q4 2021 | $16,213,000 | +7.8% | 49,280 | -0.4% | 2.82% | -1.9% |
| Q3 2021 | $15,043,000 | +13.3% | 49,485 | -0.1% | 2.88% | +10.8% |
| Q2 2021 | $13,278,000 | +18.6% | 49,544 | -0.4% | 2.60% | +8.7% |
| Q1 2021 | $11,196,000 | +0.7% | 49,760 | -0.6% | 2.39% | -0.9% |
| Q4 2020 | $11,113,000 | +2.7% | 50,059 | -0.5% | 2.41% | -7.5% |
| Q3 2020 | $10,822,000 | +21.5% | 50,334 | +0.0% | 2.61% | +8.2% |
| Q2 2020 | $8,909,000 | +28.4% | 50,333 | +0.1% | 2.41% | +3.3% |
| Q1 2020 | $6,938,000 | -9.9% | 50,272 | -0.1% | 2.34% | +8.4% |
| Q4 2019 | $7,697,000 | +6.2% | 50,306 | -0.0% | 2.15% | -2.3% |
| Q3 2019 | $7,246,000 | +1.4% | 50,319 | +0.7% | 2.20% | -0.2% |
| Q2 2019 | $7,145,000 | +28.8% | 49,967 | +18.9% | 2.21% | +22.6% |
| Q1 2019 | $5,547,000 | +36.9% | 42,023 | +6.8% | 1.80% | +16.8% |
| Q4 2018 | $4,051,000 | -5.8% | 39,332 | -0.3% | 1.54% | +8.4% |
| Q3 2018 | $4,302,000 | +10.1% | 39,465 | +0.0% | 1.42% | -1.2% |
| Q2 2018 | $3,907,000 | +1.0% | 39,464 | +0.0% | 1.44% | -3.5% |
| Q1 2018 | $3,867,000 | +6.6% | 39,462 | +1.2% | 1.49% | +9.2% |
| Q4 2017 | $3,627,000 | +6.8% | 38,996 | -1.3% | 1.37% | +2.1% |
| Q3 2017 | $3,396,000 | +2.8% | 39,494 | +0.4% | 1.34% | -1.5% |
| Q2 2017 | $3,304,000 | +9.9% | 39,332 | +12.5% | 1.36% | +6.3% |
| Q1 2017 | $3,006,000 | +32.7% | 34,956 | +20.4% | 1.28% | +24.3% |
| Q4 2016 | $2,265,000 | +2.7% | 29,034 | +2.7% | 1.03% | +1.3% |
| Q3 2016 | $2,205,000 | -19.4% | 28,273 | +4.4% | 1.02% | -19.0% |
| Q2 2016 | $2,735,000 | +24.1% | 27,082 | +16.8% | 1.26% | +22.9% |
| Q1 2016 | $2,203,000 | +44.7% | 23,186 | +41.6% | 1.02% | +38.9% |
| Q4 2015 | $1,522,000 | +49.2% | 16,370 | +36.4% | 0.74% | +44.3% |
| Q3 2015 | $1,020,000 | +286.4% | 12,000 | +291.5% | 0.51% | +295.3% |
| Q2 2015 | $264,000 | – | 3,065 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |